{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Coupons", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Medicine and Health", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "New England Journal of Medicine", "name": "organizations", "rank": "5", "is_major": "Y"}, {"value": "National Bureau of Economic Research", "name": "organizations", "rank": "6", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/10/13/upshot/drug-coupons-helping-a-few-at-the-expense-of-everyone.html", "document_type": "article", "byline": {"person": [{"lastname": "SANGER-KATZ", "firstname": "Margot", "role": "reported", "organization": "", "rank": 1}], "original": "By MARGOT SANGER-KATZ"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/10/13/business/13Up-Coupon--new/13Up-Coupon--new-thumbWide.jpg", "legacy": {"wide": "images/2016/10/13/business/13Up-Coupon--new/13Up-Coupon--new-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/10/13/business/13Up-Coupon--new/13Up-Coupon--new-articleLarge.jpg", "legacy": {"xlarge": "images/2016/10/13/business/13Up-Coupon--new/13Up-Coupon--new-articleLarge.jpg", "xlargeheight": "357", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 357}, {"url": "images/2016/10/13/business/13Up-Coupon--new/13Up-Coupon--new-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/10/13/business/13Up-Coupon--new/13Up-Coupon--new-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "The Upshot", "word_count": "1114", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Enabling patients to choose more costly alternatives can result in higher premiums, new research finds.", "pub_date": "2016-10-13T04:00:00+0000", "news_desk": "Upshot", "headline": {"kicker": "The Upshot", "print_headline": "Drug Coupons Help a Few, at the Expense of Everyone", "main": "Drug Coupons: Helping a Few at the Expense of Everyone", "content_kicker": "Public Health"}, "print_page": "3", "snippet": "Enabling patients to choose more costly alternatives can result in higher premiums, new research finds....", "_id": "57fea47a95d0e022439c2d6d", "slideshow_credits": null, "abstract": "The Upshot; coupons like one offered by drugmaker Mylan for its expensive EpiPens may help some people afford life-saving drugs, but research shows that practice could lead to higher drug costs for everyone; paper published in The New England Journal of Medicine as well as one planned for publication by National Bureau of Economic Research appear to confirm negative effect of coupons."}